BioSpyder Returns to JSOT 2025!

We’re excited to announce that BioSpyder will be attending the Japanese Society of Toxicology (JSOT) Annual Meeting for the second time this July. As we return to Japan, we look forward to connecting with the scientific community to discuss how TempO-Seq is driving high-throughput toxicology forward, enabling powerful transcriptomic insights with no RNA extraction required. 

“We are excited to participate in the Japanese Society of Toxicology conference in Japan,” said Joel McComb, CEO of BioSpyder. “As a leading player in toxicology across the U.S. and Europe, this event provides a unique platform to expand our presence in Asia and engage with innovative researchers worldwide.” 

Come stop by booth 109. 

About BioSpyder: BioSpyder is a leading provider of advanced molecular biology technologies, committed to expanding scientific capabilities in toxicology, cancer biology, and environmental health. The company's TempO-Seq platform and related approaches continue to shape the landscape of genomics research, facilitating breakthroughs in drug discovery, translational research, and diagnostics.